Your browser doesn't support javascript.
loading
Optimizing conditioning regimen with low-dose irradiation or busulfan enables the outcome of transplantation from a 6-7/8 HLA-matched donor comparable to that from an 8/8 HLA-matched unrelated donor in severe aplastic anemia patients under 40 years.
Qin, Xia; Zhu, Yi-Ping; Luo, Cheng-Juan; Zhou, Ming; Huang, Ke; Chen, Chun; Zhang, Wei-Ping; Sun, Yuan; Luo, Rong-Mu; Tang, Xiang-Feng; Yang, Ting; Song, Xian-Min; Hu, Shao-Yan; Sun, Zi-Min; Hu, Jiong; Wang, Shun-Qing; Chen, Jing.
Affiliation
  • Qin X; Department of Hematology and Oncology, National Children's Medical Center, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, 1678 Dongfang Road, Shanghai, 200127, China.
  • Zhu YP; Department of Pediatric Hematology and Oncology, West China Second University Hospital/West China Women and Children's Hospital, Sichuan University, Chengdu, China.
  • Luo CJ; Department of Hematology and Oncology, National Children's Medical Center, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, 1678 Dongfang Road, Shanghai, 200127, China.
  • Zhou M; Department of Hematology, Guangzhou First People's Hospital , School of Medicine, South China University of Technology, 1 Panfu Road, Guangzhou, 510180, Guangdong, China.
  • Huang K; Department of Pediatric Hematology and Oncology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Chen C; Department of Pediatric Hematology and Oncology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Zhang WP; Department of Hematology, Changhai Hospital, Navy Military Medical University, Shanghai, China.
  • Sun Y; Department of Hematology and Oncology, Beijing JingDu Children's Hospital, Beijing, China.
  • Luo RM; Department of Hematology and Oncology, BaYi Children's Hospital, The Seventh Medical Center of PLA General Hospital, Beijing, China.
  • Tang XF; Department of Pediatric Hematology and Oncology, The Sixth Medical Center of PLA General Hospital, Beijing, China.
  • Yang T; Department of Hematology, Fujian Medical University Union Hospital, Fuzhou, China.
  • Song XM; Department of Hematology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Hu SY; Department of Hematology and Oncology, Children's Hospital of Soochow University, Soochow, China.
  • Sun ZM; Department of Hematology, Anhui Provincial Hospital, University of Science and Technology of China, Hefei, China.
  • Hu J; Department of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Wang SQ; Department of Hematology, Guangzhou First People's Hospital , School of Medicine, South China University of Technology, 1 Panfu Road, Guangzhou, 510180, Guangdong, China. eywangshq@scut.edu.cn.
  • Chen J; Department of Hematology and Oncology, National Children's Medical Center, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, 1678 Dongfang Road, Shanghai, 200127, China. chenjing@scmc.com.cn.
Ann Hematol ; 100(9): 2363-2373, 2021 Sep.
Article in En | MEDLINE | ID: mdl-33988738

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Peloideterapia Main subject: Busulfan / Transplantation Conditioning / HLA Antigens / Immunosuppressive Agents / Anemia, Aplastic Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Language: En Journal: Ann Hematol Year: 2021 Type: Article Affiliation country: China

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Peloideterapia Main subject: Busulfan / Transplantation Conditioning / HLA Antigens / Immunosuppressive Agents / Anemia, Aplastic Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Language: En Journal: Ann Hematol Year: 2021 Type: Article Affiliation country: China